Related Experiment Video
Updated: Jul 6, 2026

06:30
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
Incorporation of Butyryl-Lysine into Phage-Displayed Peptide Libraries
Sophea Pa1, Rutendo Nyamadzawo1, Gopal Dubey1
1Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.
Methods in Molecular Biology (Clifton, N.J.)
|July 4, 2026
Summary
Researchers developed new peptide probes to study epigenetic proteins that recognize butyrylated lysine. This method advances the study of epigenetic readers, writers, and erasers for potential therapeutic development.
Area of Science:
- Epigenetics
- Molecular Biology
- Biochemistry
Background:
- Epigenetic reader proteins often recognize butyrylated lysine residues.
- Current peptide probes are largely limited to histone substrates, hindering broader research.
- Developing selective peptide substrates is crucial for studying these proteins and potential therapeutics.
Purpose of the Study:
- To produce and utilize phage-displayed peptide libraries containing butyrylated lysine residues.
- To direct phage selections toward the active sites of epigenetic proteins.
- To establish a versatile technique for studying various epigenetic modifiers.
Main Methods:
- Incorporation of Nε-butyryl-L-lysine into phage-displayed peptide libraries.
- Phage selection strategies to target epigenetic protein active sites.
- Library production and screening for specific epigenetic readers.
Main Results:
- Successfully produced phage-displayed peptide libraries with butyrylated lysine residues.
- Demonstrated the utility of these libraries in targeting epigenetic protein active sites.
- Established a foundation for identifying inhibitors of epigenetic proteins.
Conclusions:
- The developed technique enables the creation of selective peptide substrates for epigenetic readers.
- This approach can be broadly applied to study epigenetic readers, writers, and erasers.
- The method holds potential for discovering therapeutic agents for diseases involving epigenetic dysregulation.

